Discontinued — last reported Q4 '21
Insmed Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance remained flat by 0.0% to $67.83M in Q4 2025 compared to the prior quarter. Year-over-year, this metric grew by 46.4%, from $46.34M to $67.83M. Over 2 years (FY 2023 to FY 2025), Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance shows an upward trend with a 43.9% CAGR.
A reduction in the valuation allowance increases net income, while an increase reduces it.
Tracks the impact of adjustments to the valuation allowance for deferred tax assets on the effective tax rate. A valuati...
Commonly used by companies with significant carryforward tax attributes.
other_income_tax_reconciliation_change_in_deferred_tax_a_acfd4f| FY'23 | FY'24 | FY'25 | |
|---|---|---|---|
| Value | $131.04M | $185.37M | $271.34M |
| YoY Change | — | +41.5% | +46.4% |